全文获取类型
收费全文 | 53461篇 |
免费 | 3435篇 |
国内免费 | 239篇 |
专业分类
耳鼻咽喉 | 690篇 |
儿科学 | 1152篇 |
妇产科学 | 860篇 |
基础医学 | 6734篇 |
口腔科学 | 1132篇 |
临床医学 | 5253篇 |
内科学 | 11968篇 |
皮肤病学 | 667篇 |
神经病学 | 5085篇 |
特种医学 | 2489篇 |
外国民族医学 | 1篇 |
外科学 | 8984篇 |
综合类 | 417篇 |
一般理论 | 34篇 |
预防医学 | 3250篇 |
眼科学 | 962篇 |
药学 | 3079篇 |
中国医学 | 63篇 |
肿瘤学 | 4315篇 |
出版年
2023年 | 336篇 |
2022年 | 637篇 |
2021年 | 1396篇 |
2020年 | 839篇 |
2019年 | 1277篇 |
2018年 | 1541篇 |
2017年 | 1095篇 |
2016年 | 1152篇 |
2015年 | 1419篇 |
2014年 | 2029篇 |
2013年 | 2636篇 |
2012年 | 4014篇 |
2011年 | 4231篇 |
2010年 | 2423篇 |
2009年 | 2326篇 |
2008年 | 3621篇 |
2007年 | 3824篇 |
2006年 | 3478篇 |
2005年 | 3338篇 |
2004年 | 3037篇 |
2003年 | 2823篇 |
2002年 | 2483篇 |
2001年 | 600篇 |
2000年 | 471篇 |
1999年 | 507篇 |
1998年 | 556篇 |
1997年 | 434篇 |
1996年 | 322篇 |
1995年 | 310篇 |
1994年 | 253篇 |
1993年 | 244篇 |
1992年 | 237篇 |
1991年 | 250篇 |
1990年 | 211篇 |
1989年 | 189篇 |
1988年 | 170篇 |
1987年 | 182篇 |
1986年 | 151篇 |
1985年 | 170篇 |
1984年 | 187篇 |
1983年 | 156篇 |
1982年 | 152篇 |
1981年 | 129篇 |
1980年 | 113篇 |
1979年 | 128篇 |
1978年 | 102篇 |
1977年 | 86篇 |
1976年 | 70篇 |
1975年 | 65篇 |
1973年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Pieter F Vos Oliver Zilch Aag Jennekens-Schinkel Miriam Salden Jasper Nuyen Menno P Kooistra M Alexander C van Huffelen Margriet M Sitskoorn 《Nephrology, dialysis, transplantation》2006,21(9):2529-2535
BACKGROUND: End-stage renal disease patients have a poor quality of life (QoL), suffer from impaired cognitive functioning, and their electroencephalogram (EEG) shows abnormalities. Conventional haemodialysis (CHD) only partially restores these disorders. Short daily haemodialysis (SDHD) has been reported to improve QoL, but effects on cognitive functioning and EEG have yet to be described. METHODS: Of the 13 patients (11 male, 2 female, age 45.5 +/- 8.1 years), 11 completed the Kidney Disease Quality of Life and Affect Balance Scale questionnaires, 10 underwent neuropsychological testing, and all 13 underwent EEG examination. For the neuropsychological assessments, nine patients (six male, three female, age 45.4 +/- 12.6) who remained on the CHD schedule, served as controls. The dialysis schedule of thrice-a-week for 4 h was changed in the experimental group to six times a week for 2 h (SDHD) over a period of 6 months and back to thrice a week for 4 h. RESULTS: When on SDHD, patients rated several dimensions of health-related QoL as being improved. After resuming CHD, one of these dimensions again decreased and several others worsened even lower than baseline. Cognitive functioning did not change when compared with control data. On the EEG, alpha peak frequency increased slightly when on SDHD but decreased significantly after resuming CHD. CONCLUSIONS: SDHD improves health-related QoL, but has no clear effects on cognitive functioning and EEG. Resumption of CHD after SDHD decreases aspects of QoL and EEG alpha peak frequency but has no effect on cognitive functioning. 相似文献
42.
Marc Blockman 《Suid-Afrikaanse tydskrif vir geneeskunde》2006,96(6):476-7; author reply 477-8
43.
Sajeel Chowdhary MD Lisa M. Chalmers PA-C Marc Chamberlain MD 《Journal of neuroimaging》2007,17(1):69-73
In the course of 1 year at a tertiary cancer center, 3 patients (2 men; 1 woman; age 51-75 years) were seen in neurological consultation (1.5% of all consultations). Clinical course in all patients was of a progressive neurologic disorder not consistent with either a primary or secondary malignancy. Magnetic resonance (MR) imaging was most informative with respect to diagnosis and subsequent management. Brain biopsy was performed in all patients to assist in both diagnosis and prognostication. All patients were determined to have progressive multifocal leukoencephalopathy (PML) by brain biopsy. 相似文献
44.
45.
Comparison of three different purification methods for the routine preparation of [11C] Metomidate. 总被引:1,自引:0,他引:1
Markus Mitterhauser Wolfgang Wadsak Oliver Langer Joern Schmaljohann Georg Zettinig Robert Dudczak Helmut Viernstein Kurt Kletter 《Applied radiation and isotopes》2003,59(2-3):125-128
PET with (R)-[O-methyl-11C] metomidate ([11C] MTO) is an attractive method for the characterisation of adrenal masses discriminating lesions of adrenal cortical origin from noncortical lesions. [11C] MTO was prepared by the reaction of [11C] methyliodide with the corresponding free acid. Three purification methods have been compared. The method of choice uses preparative HPLC with a ready-to-use weak acidic solvent. 相似文献
46.
47.
Michael Brauckhoff Oliver Gimm Udo Bilkenroth Raoul Hinze Henning Dralle 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2002,387(5-6):201-203
BACKGROUND: In most examined populations the RET germline polymorphism S836S is found in about 3.6% of the normal population but in about 9% of patients suffering from sporadic C-cell hyperplasia or medullary thyroid carcinoma. The polymorphism S836S is thought to be involved in the development of sporadic medullary thyroid carcinoma. CASE PRESENTATION: We report a 48-year-old woman suffering from primary hyperparathyroidism (parathormone 121-166 pg/ml, normal <72), bilateral diffuse and nodular C-cell hyperplasia (calcitonin after pentagastrin administration 156 pg/ml, normal <4.6), and papillary thyroid carcinoma. Two commercial analyses of RET did not reveal any germline mutation within the known hot spots. However, sequencing revealed the presence of the RET polymorphism S836S. Following total thyroidectomy and removal of two hyperplastic parathyroid glands parathormone decreased to 51 pg/ml and calcitonin was no longer detected. CONCLUSIONS: The pathogenetic importance of the RET polymorphism S836S is still obscure. However, according to the published overrepresentation of the RET polymorphism S836S in patients suffering from apparent sporadic medullary thyroid carcinoma, it is conceivable that it also plays a role in multiglandular endocrine disease. 相似文献
48.
49.
A Coagulation Factor IX-Deficient Mouse Model for Human Hemophilia B 总被引:25,自引:10,他引:15
Lin Hui-Feng; Maeda Nobuyo; Smithies Oliver; Straight David L.; Stafford Darrel W. 《Blood》1997,90(10):3962-3966
50.
Changes in snoring characteristics after 30 days of nasal continuous positive airway pressure in patients with non-apnoeic snoring: a controlled trial. 下载免费PDF全文
BACKGROUND--A study was performed to evaluate the effect of discontinuation of nasal continuous positive airway pressure (NCPAP) treatment on snoring characteristics. METHODS--Eighteen non-apnoeic snoring subjects were randomly allocated to either a no treatment control group or an NCPAP treatment group. The control group was studied twice (baseline and day 30 of follow up). In the NCPAP group the level of NCPAP that abolished snoring was determined and part abolished snoring was determined and patients were placed on NCPAP every night for one month. A sleep study was performed on the first night without NCPAP after completing 30 days of treatment (follow up 1). A fourth polysomnographic study was performed 8-10 days after NCPAP was stopped (follow up 2) in six subjects. RESULTS--In both groups total sleep time (TST) and sleep architecture remained unchanged at the different visits. Baseline snoring characteristics in the two groups were similar. In the control group the mean (SE) number of snoring episodes/hour of sleep (snoring index) and the percentage of TST > 60 decibels (dB) were 380 (36)/h and 11.1 (2.0)% TST respectively at baseline, and was unchanged at follow up. In the NCPAP group the snoring index decreased from 387 (50)/h to 320 (57)/h after NCPAP therapy, but the % TSTS > 60 dB decreased from 10.3 (1.8)% to 7.4 (1.5)%. The snoring index and intensity returned to baseline values at follow up 2 (374 (74)/h, 9.8 (2.1)% TST). Changes in snoring characteristics could not be explained by changes in body position between the different sleep studies. CONCLUSIONS--NCPAP improves snoring but this effect is lost soon after stopping treatment. 相似文献